Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung
- 1 July 2008
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 3 (7), 704-710
- https://doi.org/10.1097/jto.0b013e31817c6080
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Impact of Sex and Smoking Status on the Mutational Spectrum of Epidermal Growth Factor Receptor Gene in Non–small Cell Lung CancerClinical Cancer Research, 2007
- Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lungLung Cancer, 2006
- Frequent EGFR mutations in brain metastases of lung adenocarcinomaInternational Journal of Cancer, 2006
- Unraveling the Mystery of Prognostic and Predictive Factors in Epidermal Growth Factor Receptor TherapyJournal of Clinical Oncology, 2006
- Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancersInternational Journal of Cancer, 2006
- Detection ofEGFRGene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction AssayClinical Cancer Research, 2006
- What are the clinical features of lung cancer before the diagnosis is made? A population based case-control studyThorax, 2005
- Objective radiologic analysis of ground-glass opacity aimed at curative limited resection for small peripheral non-small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2005
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Survival in early-stage non-small cell lung cancerThe Annals of Thoracic Surgery, 1995